Business
Currency:CNY
2024/H1
Stock NameRevenueRatio
Drug sales income98.53M90.83%
中国内地独家推广许可权收入9.95M9.17%
Product
No Data
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
The mainland of China108.48M100.00%